- In April 2023, Terumo BCT announced the expansion of its Spectra Optia Apheresis System's capabilities to include therapeutic plasma exchange for pediatric patients. This development underscores the company's commitment to addressing the unique needs of younger patients requiring apheresis treatments
- In March 2023, Fresenius Kabi launched a next-generation apheresis machine, the COM.TEC 2.0, featuring an enhanced user interface and improved efficiency. This advancement aims to streamline blood component collection processes and improve donor comfort during procedures
- In February 2023, Haemonetics Corporation received FDA approval for its NexSys PCS plasma collection system with Persona technology. This system personalizes plasma collection based on individual donor characteristics, optimizing yield and enhancing donor safety
- In January 2023, B. Braun Melsungen AG introduced an updated version of its Plasauto Sigma apheresis device, incorporating advanced monitoring features and improved automation. This upgrade is designed to increase treatment precision and reduce procedure times
- In December 2022, Asahi Kasei Medical Co., Ltd. announced the development of a new membrane-based apheresis filter, aiming to improve the selectivity and efficiency of LDL apheresis treatments. This innovation reflects the company's dedication to advancing therapeutic options for patients with refractory hypercholesterolemia
